News

Researchers added zilebesiran—a subcutaneous injection given just twice a year—to their regimen. Patients on zilebesiran saw bigger, steadier drops in systolic pressure than those on pills alone.
"We are pleased to announce the European Commission approval of the subcutaneous injection of VYVGART, which is co-formulated with our ENHANZE drug delivery technology for use in CIDP patients.
VYVGART for SC injection is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional.
There are a few different delivery systems—IVs, subcutaneous injections, nasal sprays, and of course, the best NAD+ supplements—to help address everything from loss of muscle mass to brain fog ...
To report the results of the multicenter, open-label IRAKLIA trial (ClinicalTrials.gov identifier: NCT05405166) of isatuximab subcutaneous (SC) versus intravenous (IV), plus pomalidomide and ...
The subcutaneous injection is a tyrosine kinase inhibitor designed to block all forms of VEGF, Singer explained at the Retina World Congress.
This treatment guide explains how subcutaneous PD-1 or PD-L1 inhibitor injections treat certain types of cancer.
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025 Provided by GlobeNewswire Apr 25, 2025, 10:00:00 AM ...
The White House underwent some interior decorating on Friday, as Barack Obama’s official presidential portrait was replaced with a painting depicting President Donald Trump shortly after the ...
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist ...
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting hepa ...
This article explores types of immunotherapy for upper GI cancer, how subcutaneous immunotherapy injections work, and considerations for when a doctor may add these types of therapies to a cancer ...